Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158(3):451-454 | DOI: 10.5507/bp.2012.077

Radiofrequency ablation of non-resectable lung tumors

Vaclav Simaneka, Jiri Kleckaa, Vladislav Treskaa, Kristyna Ohlidalovab, Hynek Mirkab
a Department of Surgery, University Hospital in Pilsen, Czech Republic
b Department of Imaging Methods, University Hospital in Pilsen

Background: Radiofrequency thermal ablation (RFA) is a minimally invasive, image guided technique for destroying tumour cells without damage to adjacent healthy tissue. It is used for partial or complete ablation of non resectable lung cancers and cancers of metastases to lung, providing an effective, relatively safe option for patients ineligible for surgery. We describe our experience with it.

Methods: In 2005 and 2006, we performed radiofrequency ablation of 7 lung lesions in 6 patients. RFA was done percutaneously under image guided CT scan in 5 patients and in one patient during thoracotomy when we found a radically unresectable tumor necessitating debulking. CT lung screening was performed after 6 months and PET/CT was done within 12 months.

Results: In the course of the screening, we diagnosed regression in 2 patients, a stationary state in 2 cases and local tumor progression in 2 patients, using computed tomography within 6 months after RFA. Using PET/CT within 12 months, we diagnosed non-ablation and liver metastases (there were none before) in one of the two patients with a stationary state diagnosed by means of CT before and recurrence of primary tumor in another patient. In one case of diagnosed regression, we diagnosed tumor progression. The patients survived an average of 30 months (range 9 to 60 months).

Conclusion: RFA of lung tumors is an easy method with little patient discomfort. It can be performed percutaneously using guided CT under general anaesthesia. RFA of lung tumors possibly alone or in combination with oncology treatment can prolong patient life.

Keywords: radiofrequency ablation, selective lung ventilation, lung CT scan, lung PET/CT

Received: March 28, 2012; Accepted: July 19, 2012; Prepublished online: September 5, 2012; Published: September 30, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Simanek, V., Klecka, J., Treska, V., Ohlidalova, K., & Mirka, H. (2014). Radiofrequency ablation of non-resectable lung tumors. Biomedical papers158(3), 451-454. doi: 10.5507/bp.2012.077
Download citation

References

  1. Skalicky T, Treska V. Radiofrequency ablation of liver tumors. Maxdorf 2006.
  2. Mellot F, Friard S, Doubre H, Guth A, Chapelier A, Scherrer A, Couderc LJ. Radiofrequency treatment of lung tumours. Rev Pneumol Clin 2011;67(4):238-43. Go to original source... Go to PubMed...
  3. Rao P, Escudier B, de Baere T. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol 2011;34(2):424-30. Go to original source... Go to PubMed...
  4. Bilal H, Mahmood S, Rajashenker B, Shah R. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small lung cancer? Interact Cardiovasc Thorac Surg 2012 May 10. [Epub ahead of print] doi: 10.1093/icvts/ivs179 Go to original source... Go to PubMed...
  5. Hiraki T, Gobara H, Mimura H, Toyooka S, Fujiwara H, Yasui K, Sano Y, Iguchi T, Sakurai J, Tajiri N, Mukai T, Matsui Y, Kanazawa S. Radiofrequency ablation of lung cancer at Okayama University Hospital:a review of 10 years of experience. Acta Med Okayama 2011;65(5):287-97. Go to PubMed...
  6. Ambrogi MC, Fanucchi O, Cioni R, Dini P, De Liperi A, Cappelli C, Davini F, Bartolozzi C, Mussi A. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011;6(12):2044-51. Go to original source... Go to PubMed...
  7. Hiraki T, Gobara H, Shibamoto K, Mimura H, Soda Y, Uka M, Masaoka Y, Toyooka S, Kanazawa S. Technique for creation of arteficial pneumotorax fo pain relief during radiofrequency ablation of peripheral lung tumors:report of seven cases. J Vasc Interv Radiol 2011;22(4):503-6. Go to original source... Go to PubMed...
  8. Kashima M, Yamakado K, Takaki H, Kodama H, Yamada T, Uraki J, Nakatsuka A. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: single center´s experiences. AJR Am Roentgenol 2011;197(4):W 576-80. Go to original source...
  9. Nomori H, Imazu Y, Watanabe K, Ohtsuka T, Naruke T, Kobayashi T, Suemasu K. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest2005;127(3):973-7. Go to original source... Go to PubMed...
  10. Palussiére J, Cannella M, Gómez F, Ferron S, Descat E. Stellate ganglion Indry after percutaneous radiofrequency ablation of a lung tumor. Cardiovasc Intervent Radiol 2011;34(4):873-6. Go to original source... Go to PubMed...
  11. Hiraki T, Gobara H, Mimura H, Sano Y, Toyooka S, Shibamoto K, Kishi R, Uka M, Kanazawa S. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol 2010;21(7):1129-33. Go to original source... Go to PubMed...